Clinical Trial Gurus

JUNE 13, 2021

In addition, job seekers are also scrambling to find strategies for further developing their career pathways. In this webinar, Chris and myself share some pragmatic approaches for all to implement in order to take advantage of a HOT clinical trials industry! COVID-19 has changed the way clinical research sites look for studies.

Clinical Research 52

Clinical Research Business Development Development Research 52

Velocity Clinical Research

MAY 17, 2023

in an effort to raise money and awareness promoting diversity on all levels in clinical trials. But obstacles loom for the plucky bikers, says Sergio Armani, ACRP Ride4DEI Creator, and EVP, Business Development, Helios Clinical Research. This year it's scheduled to end May 20 in Washington D.C.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Clinical Research 98

ACRP blog

OCTOBER 3, 2022

Just ask Michaele Linden-Johnson, FACHE, MBA, LCSW, director of clinical trials and business development at the Medical Center of the Americas (MCA) Foundation Cardwell Collaborative in El Paso, Texas. We’re all about developing a workforce designed to reflect our patient population,” Linden-Johnson says.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Clinical Research Coordinator 98

pharmaphorum

JANUARY 14, 2022

In the latest episode of the pharmaphorum podcast, Dr Paul Tunnah speaks to head of Patient Engagement at Syneos Health, Marie Emms, and Elligo executive vice president and general manager of Worldwide Clinical Trials Early Phase Services, Keith Fern. The post The evolution of clinical trials: the pharmaphorum podcast appeared first on.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Compliance 98

pharmaphorum

NOVEMBER 17, 2020

Pharmaceutical companies often struggle to actively involve patients in the design phase of clinical trials but doing so can have huge benefits for the sustainability and success of research. How the NIHR’s Patient Engagement in Clinical Development service can help. Gaining patient input on marketing and recruitment materials.

Clinical Trials 116

Clinical Trials Clinical Trials Trials Life Science 116

pharmaphorum

FEBRUARY 1, 2022

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinical trial design that have historically led to trial failure?

Clinical Trials 104

Clinical Trials Clinical Trials Trials Engineer 104

pharmaphorum

OCTOBER 12, 2022

Now, he leads Whitelab Genomics as its artificial intelligence (AI) platform powers the development of genomic therapies – an emerging field in which genetic sequences are injected into cells to target and repair damaged genes. We have been very impressed by their vision and the relevance of their platform.”.

Genome 105

Genome Genomics Medicine Development 105

pharmaphorum

MAY 30, 2022

Josh Sackman, president and co-founder of AppliedVR, and Web Sun, president and co-founder of Komodo Health, relay how their newly formed collaboration reshapes the clinical trial process by using data, helping to cut costs and allowing for evaluation of broader patient populations. . Distinct offerings.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Big Data 97

The Pharma Data

DECEMBER 20, 2020

Followed by Russia , Indonesia, and Korea, the second phase of the COVID-19 clinical trial was approved in Italy on Friday, December 18, 2020. Currently, it is smoothly progressing with the approval for Phase 2 clinical trials in four countries, and it is expected to see the results sequentially starting as early as the third quarter of 2021.

Clinical Trials 40

Clinical Trials Clinical Trials Development Trials 40

pharmaphorum

FEBRUARY 11, 2021

Pharma companies face many challenges when involving patients in the design of clinical trials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research.

Clinical Trials 101

Clinical Trials Clinical Trials Trials Clinical Research 101

VirTrial

FEBRUARY 4, 2020

Recognizing the need to support VirTrial’s customers around the globe, Emil Hoeck has been named International Director of Business Development and will be based in Denmark. VirTrial is a telemedicine company providing a stable, long-standing virtual care management (VCM) platform to transform the clinical trial industry.

Trials 92

Trials Research Compliance Clinical Trials 92

pharmaphorum

FEBRUARY 2, 2021

Previously viewed as a ‘nice to have’ for the pharma industry, virtual trials were already moving from a theoretical to a practical proposition before COVID-19 accelerated their transition. Increasing patient access to clinical trials. Ensuring new types of trial designs remain patient friendly.

Clinical Research 71

Clinical Research Trials Research Clinical Trials 71

XTalks

FEBRUARY 14, 2024

This episode features an interview with Yang Liu, PhD, founder, chairman, CEO and chief scientific officer; and Abid Ansari, MBA, Chief Financial Officer at OncoC4 , a clinical-stage biopharmaceutical company focused on developing novel treatments for cancer. OncoC4 is a spinout of OncoImmune, which was acquired by Merck in December 2020.

Life Science 119

Life Science DNA Production Clinical Trials 119

Pharmaceutical Technology

SEPTEMBER 14, 2022

Pharmaceutical drug research and development (R&D) activities are capital-intensive, which makes the outsourcing of clinical dose manufacturing and marketing popular. Find the leading clinical dose companies in contract marketing.

Marketing 100

Marketing Contract Manufacturing Sales Clinical Trials 100

pharmaphorum

JANUARY 14, 2021

Healthcare technology firm Seqster has introduced a new version of its service that aims to help pharma companies work with patients’ data while on virtual clinical trials. What Seqster does for pharma clinical trials is it brings together in real time a health record for participants. The new Seqster 7.1 The new Seqster 7.1

Trials 52

Trials Clinical Trials Clinical Trials Pharma Companies 52

Imperical Blog

MAY 20, 2020

If the patient can’t come to the trial, we have to bring the trial to the patient, and that is what is happening in record time. Dan McDonald, vice president, global business development. I predict a point where there is no such thing as poor attrition rates or issues with recruitment for trials. and Europe.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Genetics 52

Velocity Clinical Research

JANUARY 24, 2023

Évelyne Newton joins as Vice President of Business Development, Sandra Stark is Vice President of European Operations and Maria Lehretz is the new Medical Director at Velocity’s recently acquired site in Leipzig, Germany. She has 20 years’ experience in business development and key account management in the clinical trials arena.

Clinical Trials 52

Clinical Trials Clinical Trials Clinical Research Business Development 52

ACRP blog

MAY 5, 2024

Some of the other educational sessions from the Saturday morning lineup of topics concentrated on the intricacies of pitching the availability of clinical trials to potential participants, and on incorporating the principles of best patient engagement practices into the training of clinical research professionals. this morning (May 4).

Clinical Research 59

Clinical Research Clinical Research Coordinator Clinical Trials Clinical Trials 59

Velocity Clinical Research

APRIL 29, 2024

Velocity recently asked some key employees to come together and discuss a wide array of issues impacting diversity, equity, and inclusion (DEI) in trials. Show the benefits of clinical trials. Highlight personal success stories, says Velocity trial participant Carlos Barcenas. Be visible.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

Pharmaceutical Technology

SEPTEMBER 15, 2022

The document contains detailed information on the suppliers and their products, alongside contact details to aid your purchasing or hiring decisions.

Marketing 130

Marketing Manufacturing Generic Drugs Containment 130

Drug Discovery World

OCTOBER 18, 2023

Sara Donnelly, Director of Research Planning and Business Development at PhoenixBio USA explores why the right pre-clinical model is essential for teams wanting to advance adeno-associated virus vector-based gene therapies.

Gene Therapy 64

Gene Therapy Gene Clinical Trials Clinical Trials 64

Camargo

SEPTEMBER 23, 2020

Thomas Kassberg, Chief Business Officer, Ultragenyx. Thomas Kassberg, Chief Business Officer, Ultragenyx. I think you really need to get the feedback directly from patients and then incorporate that feedback as you think about how you’re going to develop the product to be successful. Tom Kassberg, Ultragenyx. Dan Curran, Takeda.

Business Development 136

Business Development Drugs Development Production 136

ACRP blog

APRIL 30, 2024

Staffing and retention have been the top concern at research sites since 2020, with patient recruitment and enrollment ranking second, and the complexity of clinical trials ranking third, based on WCG survey data for 2020 to 2023. Partnerships and Global Site Development at Merck, known as MSD outside the U.S. and Canada.

Clinical Research 59

Clinical Research Clinical Trials Clinical Trials Clinical Research Coordinator 59

Drug Discovery World

AUGUST 17, 2022

Tara Heitner has more than 15 years of experience in the biopharmaceutical industry and has been involved in the development and commercialisation of early-stage drug discovery technologies to large pharma business development. TikoMed has appointed Tara Heitner and Pete Zorn to its Board of Directors.

Business Development 52

Business Development Clinical Trials Clinical Trials Drugs 52

Drug Discovery World

JANUARY 30, 2024

Natalia Elizalde, Chief Business Development Officer, VIVEbiotech, says that Dr Naldini’s award represents the significant benefits and demonstrated safety of the therapies developed using lentiviral vectors that are being used for more and more clinical trials and more prevalent diseases.

Gene Therapy 71

Gene Therapy Manufacturing Gene Clinical Trials 71

Drug Discovery World

FEBRUARY 12, 2024

Cameron Ross, SVP, Generative AI, Elsevier “AI has the potential to dramatically shorten one of the most costly areas of early drug development – small molecule discovery. We’re already seeing biotechs making breakthroughs with AI in this area, with more than 150 small molecule drugs discovered and 15 already in clinical trials.

Genome 139

Genome Genomics Life Science Gene Therapy 139

Drug Discovery World

DECEMBER 21, 2022

million (US$2 million) from Innovate UK’s Biomedical Catalyst 2022 funding competition, to accelerate development of a first-in-class disease modifying therapy for Huntington’s disease. . This latest funding from Innovate UK will enable us to accelerate development of our antibody and deliver some hope for patients.” . The post £1.7M

Antibody 52

Antibody Clinical Trials Clinical Trials Business Development 52

The Pharma Data

NOVEMBER 23, 2020

Berkien will join Ultimovacs from his current position at Amgen as Director Global Business Development. At Ultimovacs, he will lead all business and corporate development efforts and continue to maintain and foster connections with leading biotechnology and pharmaceutical companies. “In

Business Development 52

Business Development Clinical Trials Clinical Trials Licensing 52

Pharmaceutical Technology

APRIL 26, 2023

Electronic respiratory health company Adherium has also developed a digital inhaler system focusing on patient adherence, remote monitoring, and data management. There is also huge potential to use these data to inform future drug development and clinical trials of new asthma medication,” adds Chan.

Clinical Trials 289

Clinical Trials Clinical Trials Allergies Research 289

Pharmaceutical Technology

JULY 29, 2022

CAMP4’s CSO David Bumcrot PhD tells Pharmaceutical Technology that the company plans to see clinical trials go forward for their urea cycle disorder programs late next year. Ultragenyx Pharmaceuticals has an orthinine transcarbamylase (OTC) activator drug in Phase III trials. Future Possibilities.

RNA 245

RNA Gene Expression Gene Gene Therapy 245

BioTech 365

OCTOBER 14, 2020

Vaccine manufacturing and regulatory expert and business development and strategy leader bring further expertise as company advances RSV vaccine candidate into Phase 2 and scales production of an intranasal COVID-19 vaccine candidate for clinical trials REDWOOD CITY, Calif.–(BUSINESS

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52

pharmaphorum

AUGUST 30, 2022

The Cardiff-based company’s pipeline also includes an oral testosterone in clinical trials for hypogonadism, as well as a modified-release levothyroxine for hypothyroidism and oligonucleotide-based therapy for Cushing’s disease in preclinical development. The company has forecast sales of Ingrezza will reach up to $1.4

Hormones 105

Hormones Sales Clinical Trials Clinical Trials 105

pharmaphorum

JULY 1, 2022

Sixth Street is paying the biotech $250 million upfront for a share of future royalties on Ayvakit and follow-up BLU-263, in a deal that also provides up to $660 million in credit facilities that can be used for business development. Blueprint is drawing $150 million of that straight away. billion if needed.

Business Development 52

Business Development Medicine Sales Marketing 52

Pharmaceutical Technology

SEPTEMBER 1, 2022

In the pursuit of improving patient care, the continued development of POC testing can help support future demand for rapid diagnosis and treatment, with opportunities to implement successful POC facilities expanding over the years as the technology has improved.

Manufacturing 130

Manufacturing Bacterium Reagent Production 130

pharmaphorum

AUGUST 8, 2022

CRISPR Therapeutics and Vertex are also in the running with their gene-editing candidate CTX001, in phase 1/2 trials which are due to generate final results later this year. GBT’s inclacumab – another P-selectin antibody that could encroach on Adakveo – is in a pair of phase 3 trials due to generate results next year.

Marketing 111

Marketing Sales Gene Editing Antibody 111

Pharmaceutical Technology

JUNE 19, 2023

According to GlobalData’s clinical trials database, there are currently 1,231 planned and ongoing trials for gene therapies and gene-modified cell therapies alone. It’s much more complex and it has to be 100% correct, or else patients are really at risk,” explains Michael MacNeir, vice president of Business Development, Sharp Clinical.

Gene Therapy 130

Gene Therapy Gene Packaging Packaging 130

pharmaphorum

JULY 26, 2022

Comparatively, realising the potential of therapeutic vaccines has been a challenging journey, with disappointing trial results dampening initial enthusiasm. For Christopher Oelkrug, Director of Business Development for Advanced Clinical, it’s an exciting time to investigate the clinical efficacy of therapeutic cancer vaccines.

Vaccination 52

Vaccination Vaccine Business Development Trials 52